SEC recommends to upgrade Corbevax from restricted use in emergency situation to new drug
The Subject Expert Committee (SEC), which advises the central drug regulatory authority on new drugs and clinical trials, has recommended to upgrade the status of approval for Biological E's Covid-19 vaccine Corbevax from restricted use in emergency …